CD4 and Parkinson disease: Eight were expressed also in CSF-derived EVs in patients with PD (CD4, CD19, CD2, CD1c, HLA-I, CD41b, CD29, and CD45), 10 in patients with MSA (CD4, CD19, CD2, CD1c, HLA-I, MCSP, CD146, CD41b, CD29, and CD45), and 6 in patients with AP-Tau (CD4, CD2, CD1c, HLA-I, CD41b, and CD45) (Figure 5).